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Introduction
Systemic AA amyloidosis is a life-threatening complication
of different chronic infectious and inflammatory diseases.
The deposition of amyloid fibrils derived from the serum
amyloid A (SAA) protein represents its pathological hall-
mark. A long lasting and increased serum level of SAA is a
prerequisite to its development. The group of inherited
autoinflammatory diseases includes different disorders
consequence of a genetically-determined dysregulation of
innate immune system. All these diseases are associated
with a marked acute phase response. The incidence of AA
amyloidosis varies widely among them, with the higher
incidence in Muckle-Wells syndrome and in TNF recep-
tor-associated periodic syndrome. Inversely, no cases of
AA amyloidosis have been reported in some few inherited
autoinflammatory diseases, including Blau syndrome, a
dominantly-inherited disease caused by NOD2 mutations.
Case report
The patient is a 30 years-old woman that referred since
the 21 months of age persistent fever, chronic polyarthri-
tis, skin rash, and ocular manifestations including recur-
rent bilateral uveitis. Granulomatous infiltration was
detected in synovial biopsies, with negative results for
microbiologic test. Her mother and sister were also
affected by a similar disease, suggesting an autosomal
dominant inheritance pattern. A clinical diagnosis of Blau
syndrome was proposed. The NOD2 analyses revealed a
heterozygous c.1759C>T transition that provokes the
novel p.Arg587Cys mutation. This mutation was subse-
quently detected in her affected relatives, and established
the definitive diagnosis of Blau syndrome.
At 25 year-old she became pregnant, and during the
pregnancy, proteinuria was detected in the first and
second quarter, without other accompanying signs. Protei-
nuria disappeared in the third quarter. After delivery, sev-
eral episodes of intense uveitis were detected, and treated
with corticosteroids. Methotrexate (MTX) was also added
to modify the inflammatory disease activity and to prevent
the recurrence of uveitis. However, one year later, MTX
was discontinued to avoid potential teratogenic effects in a
future pregnancy.
During the follow-up, different routine tests revealed
repeatedly glomerular-range proteinuria, with normal
urine sediment and preserved renal function. A renal
biopsy was performed and pathological studies revealed
Congo-red positive deposits with glomerular and vascular
involvement. Immunohistochemical studies revealed that
these deposits were of AA-type. Antiproteinuric measures
were started, and proteinuria decreased after 5 months of
treatment.
Discussion
This case represents the first description of AA amyloido-
sis in Blau syndrome. It highlights the relevance of moni-
toring the renal function in the follow-up of patients
affected by any inherited autoinflammatory disease, inde-
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